dr. willmott on mechanisms of resistance in ovarian cancer
Published 6 years ago • 361 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
0:22
copy of dr. willmott on mechanisms of resistance in ovarian cancer
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
7:27
parp inhibitor mechanisms of resistance
-
0:57
dr. westin on parp resistance in ovarian cancer
-
1:30
dr. mirza on the evolving treatment landscape in recurrent ovarian cancer
-
1:13
dr. mccann on resistance mutations in ovarian cancer
-
0:58
dr. cohen on the evolution of surgery in ovarian cancer
-
1:30
dr. fowler on considerations for cytoreductive surgery in ovarian cancer
-
14:46
managing platinum-resistant ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:44
dr. zamarin on priming strategies in ovarian cancer
-
2:03
dr. wenham on trials evaluating ip, iv, and dose-dense chemotherapy in ovarian cancer
-
2:53
neoadjuvant therapy versus surgery for ovarian cancer
-
6:03
gog-0218: frontline bevacizumab in ovarian cancer
-
2:28
dr. moore on the role of mirvetuximab soravtansine in ovarian cancer
-
0:13
copy of dr. karam on primary debulking surgery versus neoadjuvant chemotherapy in ovarian cancer
-
1:02
dr. wenham on rationale for novel immunotherapy combos in ovarian cancer
-
5:25
platinum resistance in ovarian cancer
-
1:06
dr. burgess on parp resistance in ovarian cancer